GEN - Genetic Engineering and Biotechnology News
Get the latest news and information on genetic engineering and biotechnology including analysis, features, webinars, podcasts, and more.
Top 10 Contract Development and Manufacturing Organizations
2023年9月15日 · GEN’s first-ever Top 10 A-List of contract developers and manufacturers is here. Of the top 10 companies listed, only three are headquartered in the U.S.; the rest are based in …
Top 10 RNA-Based Biopharmas - genengnews.com
2021年11月17日 · In GEN’s initial A-List published in 2018, the top five public companies generated a combined $1.536 billion in revenues for 2017 and the first three quarters of …
Top 25 Biotech Companies of 2024 - genengnews.com
2024年1月12日 · However, biotechnology remains a profitable investment in the long term. Over the past five years, the market cap for the top 25 biotechnology companies soared nearly 78% …
Top 10 Sequencing Companies
2018年4月9日 · By 2022, the global next-generation sequencing (NGS) market has been projected to reach between $10.5 billion (BCC Research) and $12.45 billion …
Top 25 Biotech Companies of 2023 - genengnews.com
2023年5月5日 · Top 25 Biotech Companies of 2023. Combined market cap soars 17% over the past year with most of the largest public companies gaining value and biopharma …
Top 10 Contract Development and Manufacturing Organizations …
2024年8月23日 · This year, GEN’s list of top 10 contract development and manufacturing organizations is led by Lonza, which works across five continents and relies on a global …
Current Issue Archives - GEN - Genetic Engineering and …
Volume 43, Issue No. 09, September 2023. It’s September, that time of year when back-to-school feelings come over us whether we’re enrolled in school or not.
About GEN
The exclusive features, reporting, and analysis in GEN enable new scientific discoveries, accelerate the pace of research, and drive large-scale funding and investments.
Top 10 Synthetic Biology Companies - genengnews.com
2021年7月2日 · Investors pumped $4.6 billion into synthetic biology or “synbio” companies—more than four times the $904.7 million invested in the sector during Q1 2020, according to figures …